Cerebrospinal fluid levels of orexin-A are not a clinically useful biomarker for Huntington disease.
Björkqvist
M
M
Petersén
A
A
Nielsen
J
J
Ecker
D
D
Mulder
H
H
Hayden
M R
MR
Landwehrmeyer
B
B
Brundin
P
P
Leavitt
B R
BR
D000818:Animals; D015415:Biomarkers / Q000134:cerebrospinal fluid; D016022:Case-Control Studies; D005260:Female; D006801:Humans; D000071058:Huntingtin Protein; D006816:Huntington Disease / Q000134:cerebrospinal fluid*; D047908:Intracellular Signaling Peptides and Proteins / Q000134:cerebrospinal fluid*; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D008875:Middle Aged; D009419:Nerve Tissue Proteins / Q000235:genetics; D009479:Neuropeptides / Q000134:cerebrospinal fluid*; D009687:Nuclear Proteins / Q000235:genetics; D000068797:Orexins; D011994:Recombinant Proteins / Q000235:genetics
D015415:Biomarkers; C000596229:HCRT protein, human; C086055:HTT protein, human; D000071058:Huntingtin Protein; D047908:Intracellular Signaling Peptides and Proteins; D009419:Nerve Tissue Proteins; D009479:Neuropeptides; D009687:Nuclear Proteins; D000068797:Orexins; D011994:Recombinant Proteins